The CXCR1/CXCR2 ligand-receptor axis has been widely characterized as a driver of aggressive behavior in many cancer types, including breast, prostate, melanoma, lung, colorectal, pancreatic, and renal cancers [6]. Here, CXCR1 is linked to melanoma.